A Methocarbamol Combination to Prevent Toxicity of Non-steroidal Anti Inflammatory Drugs
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
To prevent toxicity from both robax platinum (methocarbamol, ibuprofen) and robaxacet (methocarbomol, acetaminophen), separately, we used stretches and naproxen as a non-steroidal anti-inflammatory drug (NSAID) to compare each effectiveness. This study used the United States Forces Korea Prescription form (Annex A-Over-The-Counter Prescription) and Alice Rich’s Pain scale with robax platinum, robaxacet including narproxen. The IBM SPSS statics version 24 was used to calculate the data. The combined methocarbamol 500 mg, acetaminophen 325 mg tablet, and ibuprofen 200 mg (or naproxen) tablet can work as well as the combined methocarbamol 500 mg tablet with acetaminophen 325 mg tablet with stretches. Both methods were successful in managing pain. The drug combination of methocarbamol 500 mg, acetaminophen 325 mg and ibuprofen 200 mg tablets yielded similar benefits as the methocarbamol 500 mg and acetaminophen 325 mg tablets paired with physical stretching exercises regarding managing overall pain.
Abstract
To prevent toxicity from both robax platinum (methocarbamol, ibuprofen) and robaxacet (methocarbomol, acetaminophen), separately, we used stretches and naproxen as a non-steroidal anti-inflammatory drug (NSAID) to compare each effectiveness. This study used the United States Forces Korea Prescription form (Annex A-Over-The-Counter Prescription) and Alice Rich’s Pain scale with robax platinum, robaxacet including narproxen. The IBM SPSS statics version 24 was used to calculate the data. The combined methocarbamol 500 mg, acetaminophen 325 mg tablet, and ibuprofen 200 mg (or naproxen) tablet can work as well as the combined methocarbamol 500 mg tablet with acetaminophen 325 mg tablet with stretches. Both methods were successful in managing pain. The drug combination of methocarbamol 500 mg, acetaminophen 325 mg and ibuprofen 200 mg tablets yielded similar benefits as the methocarbamol 500 mg and acetaminophen 325 mg tablets paired with physical stretching exercises regarding managing overall pain.
참고문헌 (29)
- Nicholson JK, "Platform for studying drug toxicity and gene function", Nat Rev Drug Discov, 1(2), pp.153~161 (2002)
- Alam MJ, "Synthesis, anti-inflammatory, analgesic, COX1", 2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues, 2016, pp.10, 3529~3543
- Jung JY, "Hydrogen NMR-based metabolic profiling of naproxen-induced toxicity in rats", Toxicology Letters, 200(1), pp.1~7 (2011)
- Sanwal V, "Puromycin aminonucleoside induces glomerular epithelial cell apoptosis", Exp Mol Pathol, 70(1), pp.54~64 (2001)
- Flamenbaum W, "Uranyl nitrate-induced acute renal failure in the rat: Micropuncture and renal hemodynamic studies", Kidney Int Rep, 6(6), pp.408~418 (1974)
- Peter HY, "2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase", Biochem Pharm, 61(6), pp.741~748 (2001)
- Wideman GL, "Analgesic efficacy of a combination of hydrocodone with ibuprofen in postoperative pain", CPT Pharmacometrics Syst Pharmacol, 65(1), pp.66~76 (1999)
- "0 – 10Comparative pain scale" (2016)[URL]
- Bruce RB, "Metabolism of methocarbamol in the rat, dog, and human", J Pharm Sci, 60(1), pp.104~106 (1971)
- Prescott, LF, "Paracetamol (acetaminophen)", pp.140~156 (1996), CRC press
- Fortuny J, "Use of Analgesics and Nonsteroidal Anti-inflammatory Drugs, Genetic Predisposition, and Bladder Cancer Risk in Spain", Cancer Epidemiology, 15(9), pp.1696~1702 (2006)
- Hamman MA, "Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C", Biochem Pharmacol, 54(1), pp.33~41 (1997)
- Neunzig I, "Production and NMR analysis of the human ibuprofen metabolite 3-hydroxyibuprofen", J Biotechnol, 157(3), pp.417~420 (2012)
- Davies NM, "Clinical pharmacokinetics of ibuprofen. The first 30years", Clin Pharmacokinet, 34(2), pp.101~154 (1998)
- Dahlin DC, "N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen", Proc Natl Acad Sci, 81(5), pp.1327~1331 (1984)
- Dong H, "Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen", Drug Metab Dispos, 28(12), pp.1397~1400 (2000)
- Raucy JL, "Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2", Arch Biochemd Biophys, 271(2), pp.270~283 (1989)
- Jollow DJ, "Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo", J Pharmacol Exp, 187(1), pp.195~202 (1973)
- Lai MW, "2005 Annual Report of the American Association of Poison Control Centers’ National Poisoning and Exposure", Cli Toxic, 44, pp.803~932 (2006)
- "Acetaminophen dosage" (2016)[URL]
- "Naproxen dosage" (2016)[URL]
- Thomas ED, "Exercise in the Management of Chronic Back Pain", Ochsner J, 14(1), pp.101~107 (2014)
- "Methocarbamol dosage" (2016)[URL]
- Hinson JA, "Mechanism of paracetamol toxicity", Lancet, 335(8691), pp.732~ (1990)
- Kearney PM, "Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis. Meta-analysis of randomised trials", BMJ, 332(7553), pp.1302~1308 (2006)
- Bjarnason I, "Intestinal permeability in the pathogenesis of NSAID-induced enteropathy", J Gastroenterol, 44(19), pp.23~29 (2009)
- Bombardier C, "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis", N Engl J Med, 343, pp.1520~1528 (2000)
- Mansuy D, "Metabolism of xenobiotics with beneficial and adverse effects", Biol Aujourdhui, 207(1), pp.33~37 (2013)
- Kenney WL, "Physiology of sport and exercise", pp.213~218 (2015), Human kinetics